Verona Pharma plc   Report issue

For profit Phase 2 Phase 3
Founded: London United Kingdom (2005)

Organization Overview

First Clinical Trial
2014
NCT02307162
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Verona Pharma Inc | Verona Pharma plc